GSK's
Education · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
483 Green Lanes, London, Greater London,...Website
www.gskstemeducation.comRevenue
<$5 MillionIndustry
About GSK's
Is GSK's your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if GSK's is spiking on competitors!
Funding: Get notified immidiatlly once GSK's has new funding data
Product Launch: Get notified when GSK's launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if GSK's has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on GSK's recently announced quarterly report
GSK's, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at GSK's
Click to see if GSK's had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at GSK's
Find 3 more new buyers
Company Profile Activity
Activity Insights
GSK's is experiencing very low activity levels compared to other companies in the Education sector.
What does this means?
GSK's is drawing exceptional interest within the Education industry, suggesting notable developments or strong market momentum, learn more about GSK's.
GSK's Tech Stack
A closer look at the technologies used by GSK's
GSK's News & Media
S&C Advises Investor Deerfield on GSK's $10.6 Billion Acquisition of Nuvalent
GSK has agreed to acquire Nuvalent, a Boston-based clinical-stage biopharmaceutical company focused on creating precisely targeted oncology therapies, for $10.6 billion. Sullivan & Cromwell represented Deerfield, Nuvalent’s largest stockholder, on the transaction.Evaluating GSK's 34% Rise as Pipeline Progress Sparks New Valuation Debate
Wondering if GSK is actually undervalued or if there's more to the story than recent headlines suggest? You're not alone, and we're about to dive into what those numbers really mean. Despite a slight dip of 0.7% in the last week, GSK shares have surged 9.1% over the past month and are up 34.0% over the last year, adding plenty of fuel to the "value" vs. "momentum" debate. Much of the recent price movement followsGSK's (LON:GSK) Solid Profits Have Weak Fundamentals
Unsurprisingly, GSK plc's ( LON:GSK ) stock price was strong on the back of its healthy earnings report. However, we...GSK's Emma Walmsley to step down as CEO - European Pharmaceutical Review
In a surprise announcement, she will be replaced at the UK pharma company by its Chief Commercial Officer Luke Miels.
Top Education Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding GSK's
ASE Resource Hub is a comprehensive platform designed to support science education professionals by providing expert guidance, teaching materials, and resources. It offers a wide range of materials for primary, secondary, and post-16 educators, as well as resources specifically for science technicians. The hub also features a community for teacher... Read More